Ads
related to: inovio pharmaceuticals hiv results report example- Find A Testing Center
Locate A Testing Center Near You.
Learn More Today.
- Take A Healthy Sex Quiz
Get Started (So You Can Get Busy) -
Answer Some Questions About Sex.
- Find A Testing Center
Search results
Results From The WOW.Com Content Network
Today I'd like to provide an overview of Inovio's financial results for the third quarter of 2024. As Jackie noted at the start of the call, we are primarily focused on advancing INO-3107 and our ...
Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q2 2024 Earnings Call Aug 08, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
Inovio Pharmaceuticals Inc (NASDAQ:INO) reported its latest quarterly earnings results after the bell Wednesday, with revenue and earnings rising year-over-year. The pharmaceutical company ...
In April 2020, Inovio began a Phase I trial of the COVID-19 vaccine candidate, INO-4800. [19] In May 2021, Inovio announced the results of preclinical studies on a "pan-SARS-CoV-2" DNA vaccine (INO-4802) and plans to initiate phase I/II studies.
The report discloses that a single 350 mg subcutaneous injection of PRO 140 resulted in a HIV-1 RNA viral load reduction greater than 0.5log or 68% within one week compared with those who received a placebo. The primary efficacy endpoint results were presented at ASM Microbe 2018.
SARS-CoV-2 and HIV-1 have similarities—notably both are RNA viruses—but there are important differences. As a retrovirus, HIV-1 can insert a copy of its RNA genome into the host's DNA, making total eradication more difficult. [156] The virus is also highly mutable making it a challenge for the adaptive immune system to develop a response.
Ads
related to: inovio pharmaceuticals hiv results report example